Arq narrows Q2 loss but pauses GAC production through 2027 amid design flaws
ARQ sits 34% above its 52-week low of $1.54.
Summary
Arq reported a smaller Q2 loss on stronger sales, but halted GAC production through 2027 due to persistent design flaws, raising questions about the viability of a key growth project.
Key Events · Earnings and Guidance · ARQ
-
Q2 Loss Narrows
Net loss of $0.7M vs. $2.4M in Q2 2025; revenue up 5% to $29.9M on higher pricing and volumes.
-
GAC Production Halted
Granular activated carbon production paused for 2026 and 2027 due to design flaws; engineering review underway to assess economic viability.
-
Tight Liquidity
Unrestricted cash of $0.9M, $21.4M drawn on $30M revolver; management expects sufficient liquidity for next 12 months.
-
Accounting Change
Changed method for plant turnaround costs from direct-expense to deferral, reducing reported losses; applied retrospectively.
Analysis · ARQ · Industrial Applications And Services
Arq's Q2 results show a narrower net loss of $0.7M versus $2.4M a year ago, helped by higher pricing and volumes for its activated carbon products. However, the company confirmed it will not produce granular activated carbon (GAC) in 2026 or 2027 due to design flaws at its Red River Plant, and is conducting an engineering review to determine if the facility can be economically viable. With only $0.9M in unrestricted cash and $21.4M drawn on its $30M revolver, liquidity is tight but management says it's sufficient for the next 12 months. The filing also reflects a change in accounting for plant turnaround costs that reduced reported losses.
At the time of this filing, ARQ was trading at $2.07 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $88.9M. The 52-week trading range was $1.54 to $7.89. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.